JP2022512646A5 - - Google Patents

Info

Publication number
JP2022512646A5
JP2022512646A5 JP2021519609A JP2021519609A JP2022512646A5 JP 2022512646 A5 JP2022512646 A5 JP 2022512646A5 JP 2021519609 A JP2021519609 A JP 2021519609A JP 2021519609 A JP2021519609 A JP 2021519609A JP 2022512646 A5 JP2022512646 A5 JP 2022512646A5
Authority
JP
Japan
Prior art keywords
seq
antibody
antigen
nos
binding fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021519609A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022512646A (ja
JP7459075B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/055144 external-priority patent/WO2020076790A1/en
Publication of JP2022512646A publication Critical patent/JP2022512646A/ja
Publication of JP2022512646A5 publication Critical patent/JP2022512646A5/ja
Application granted granted Critical
Publication of JP7459075B2 publication Critical patent/JP7459075B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021519609A 2018-10-09 2019-10-08 スタフィロコッカス・アウレウス(Staphylococcus aureus)ロイコトキシンに対して向けられた抗体 Active JP7459075B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862743501P 2018-10-09 2018-10-09
US62/743,501 2018-10-09
PCT/US2019/055144 WO2020076790A1 (en) 2018-10-09 2019-10-08 Antibodies directed against staphylococcus aureus leukotoxins

Publications (3)

Publication Number Publication Date
JP2022512646A JP2022512646A (ja) 2022-02-07
JP2022512646A5 true JP2022512646A5 (cg-RX-API-DMAC7.html) 2022-10-18
JP7459075B2 JP7459075B2 (ja) 2024-04-01

Family

ID=68393067

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021519609A Active JP7459075B2 (ja) 2018-10-09 2019-10-08 スタフィロコッカス・アウレウス(Staphylococcus aureus)ロイコトキシンに対して向けられた抗体

Country Status (11)

Country Link
US (2) US11059884B2 (cg-RX-API-DMAC7.html)
EP (1) EP3864040A1 (cg-RX-API-DMAC7.html)
JP (1) JP7459075B2 (cg-RX-API-DMAC7.html)
KR (1) KR102960761B1 (cg-RX-API-DMAC7.html)
CN (1) CN113015745B (cg-RX-API-DMAC7.html)
AU (1) AU2019359207B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021006704A2 (cg-RX-API-DMAC7.html)
CA (1) CA3115765A1 (cg-RX-API-DMAC7.html)
MX (1) MX2021004114A (cg-RX-API-DMAC7.html)
TW (1) TWI895248B (cg-RX-API-DMAC7.html)
WO (1) WO2020076790A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2917360B1 (en) * 2012-11-06 2020-01-08 Medlmmune, LLC Antibodies to s. aureus surface determinants
MX2021000889A (es) 2018-07-24 2021-04-28 Medimmune Llc Anticuerpo dirigido contra el factor de agregación a (clfa) de s. aureus.
WO2020076790A1 (en) 2018-10-09 2020-04-16 Medimmune, Llc Antibodies directed against staphylococcus aureus leukotoxins
MX2021004173A (es) 2018-10-09 2021-09-08 Medimmune Llc Combinaciones de anticuerpos dirigidos contra staphylococcus aureus.
JP7682795B2 (ja) 2019-03-13 2025-05-26 メディミューン,エルエルシー コロニー形成患者における黄色ブドウ球菌(Staphylococcus aureus)感染症の低減
CN113493510A (zh) * 2021-07-07 2021-10-12 上海交通大学 一种牛源抗金黄色葡萄球菌LukD毒力因子的单链抗体及其制备和应用
CN113583119B (zh) * 2021-07-07 2023-05-02 西北农林科技大学 抗金黄色葡萄球菌的纳米抗体Nb56、应用及试剂盒

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7658921B2 (en) 2000-12-12 2010-02-09 Medimmune, Llc Molecules with extended half-lives, compositions and uses thereof
AU2002368077B2 (en) 2001-07-12 2010-03-04 Jefferson Foote Super humanized antibodies
US20040014194A1 (en) 2002-03-27 2004-01-22 Schering Corporation Beta-secretase crystals and methods for preparing and using the same
JP5675109B2 (ja) 2007-02-20 2015-02-25 アナプティスバイオ インコーポレイティッド ライブラリーの生成方法及びその使用
CN102387814A (zh) 2009-01-29 2012-03-21 米迪缪尼有限公司 延长体内半衰期的人抗il-6抗体及其在治疗肿瘤、自身免疫性疾病和炎症性疾病中的应用
LT3444268T (lt) * 2010-05-05 2022-04-11 New York University Staphylococcus aureus leukocidinai, terapinės kompozicijos ir jų panaudojimo būdai
RS58190B2 (sr) 2011-02-08 2021-08-31 Medimmune Llc Antitela koja specifično vezuju staphylococcus aureus alfa toksin i postupci njihove primene
EP2917360B1 (en) 2012-11-06 2020-01-08 Medlmmune, LLC Antibodies to s. aureus surface determinants
ES2912267T3 (es) 2012-11-06 2022-05-25 Medimmune Llc Métodos de tratamiento de enfermedades asociadas a S. aureus
CN105873946A (zh) * 2013-10-17 2016-08-17 阿尔萨尼斯生物科学有限责任公司 交叉反应性金黄色葡萄球菌抗体序列
JP6832709B2 (ja) 2014-05-16 2021-02-24 メディミューン,エルエルシー 新生児Fc受容体結合が改変されて治療および診断特性が強化された分子
TWI719938B (zh) 2014-06-19 2021-03-01 美商麥迪紐有限責任公司 多重細菌感染之治療
AU2016249837A1 (en) 2015-04-17 2017-09-28 Arsanis Biosciences Gmbh Anti-staphylococcus aureus antibody combination preparation
US20190077851A1 (en) 2015-10-30 2019-03-14 Bruno Francois Methods of using anti-alpha toxin antibody
MX2021000889A (es) 2018-07-24 2021-04-28 Medimmune Llc Anticuerpo dirigido contra el factor de agregación a (clfa) de s. aureus.
MX2021004173A (es) * 2018-10-09 2021-09-08 Medimmune Llc Combinaciones de anticuerpos dirigidos contra staphylococcus aureus.
WO2020076790A1 (en) 2018-10-09 2020-04-16 Medimmune, Llc Antibodies directed against staphylococcus aureus leukotoxins

Similar Documents

Publication Publication Date Title
EP3689909A1 (en) Tigit antibody, antigen-binding fragment thereof, and medical use thereof
JP2022512647A5 (cg-RX-API-DMAC7.html)
JP2021530244A5 (cg-RX-API-DMAC7.html)
US20050288491A1 (en) Super-humanized antibodies against respiratory syncytial virus
JP2011509245A5 (cg-RX-API-DMAC7.html)
RU2010100638A (ru) Композиции и способы лечения, направленные против cd20
JP2023528235A5 (cg-RX-API-DMAC7.html)
JP7821159B2 (ja) Bcmaと結合する単一可変ドメイン及び抗原結合分子
RU2012112340A (ru) Гуманизированные моноклональные антитела к сеа с созревшей аффинностью
JP2018526981A5 (cg-RX-API-DMAC7.html)
JP2023549537A5 (cg-RX-API-DMAC7.html)
JP2020514277A5 (cg-RX-API-DMAC7.html)
JP2023551027A5 (cg-RX-API-DMAC7.html)
HRP20120701T1 (hr) Humana monoklonska protutijela protiv fukozil-gm1 i postupci za uporabu antifukozil-gm1
RU2019121086A (ru) Иммунотерапия с применением антител, связывающих лиганд 1 белка программируемой смерти клеток (PD-L1)
JP2022533538A5 (cg-RX-API-DMAC7.html)
JP2024001073A5 (cg-RX-API-DMAC7.html)
CN116836269A (zh) 抗呼吸道合胞病毒的单克隆抗体及其应用
AU2026202717A1 (en) Anti c-met antibodies
JP2024537323A5 (cg-RX-API-DMAC7.html)
JP2024540148A5 (cg-RX-API-DMAC7.html)
CN109721656B (zh) 靶向rankl的治疗性抗体
JP2023550628A5 (cg-RX-API-DMAC7.html)
JP2020513759A5 (cg-RX-API-DMAC7.html)
CN113015745A (zh) 针对金黄色葡萄球菌白细胞毒素的抗体